SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to significant institutional accumulation and speculative buyout activity, as investors anticipate major clinical updates following the company's strong revenue growth in cell therapy. The community is actively debating the potential for an acquisition by J&J or another pharmaceutical suitor, fueled by recent heavy call options volume and the belief that the stock is currently undervalued relative to its CAR-T pipeline potential.

Re is an internet-native marketplace for insurance capital. It connects eligible capital providers with fully collateralized reinsurance activity conducted through licensed insurance entities. Blockchain infrastructure makes collateral, reserves, and selected operating data verifiable onchain. RE is the governance token of the Re Protocol. It governs protocol upgrades, technical permissions, committee formation, reporting standards, incentive policy, and governance procedures. Underwriting, claims, pricing, reserve decisions, and regulated operations remain with qualified professionals and licensed entities.

RE is trending due to recent listings on major trading platforms and active community interest in its focus on bringing the reinsurance market onchain. Investors are closely monitoring its price action and low circulating supply, with many debating the long-term potential of its real-world asset infrastructure.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors weigh strong production and delivery momentum against ongoing scrutiny of its corporate culture and production delays. The community remains sharply divided, with bulls pointing to the company's massive backlog and FCF growth as signs of a turnaround, while bears focus on labor challenges, debt levels, and the persistent volatility associated with the stock's recent performance.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Internet Computer (ICP) is attracting investor attention as the community focuses on its potential as a sovereign cloud infrastructure and its ongoing integration into AI-native government pilots. While sentiment remains divided between technical skepticism over past price action and bullish anticipation of upcoming enterprise cloud engine adoption, investors are actively discussing the project's utility and its divergence from broader crypto market trends.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors react to the project's v4 launch and a new revenue-sharing model that distributes earnings from its decentralized GPU compute network to node runners and stakers. Community sentiment is driven by a supply shock narrative, as a high percentage of the circulating supply remains locked in long-term staking pools.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports is trending as investors weigh its potential as essential infrastructure for the emerging prediction market sector against concerns over ongoing regulatory scrutiny and increased industry competition. The community is actively discussing the company's long-term growth opportunities in sports data, media, and fan engagement while debating the recent volatility and the potential impact of prediction market developments on the broader sports betting landscape.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is experiencing significant volatility and price swings as community members debate whether the stock is a long-term turnaround play or a heavily manipulated retail momentum trade. Investors are actively tracking the impact of recent SEC subpoena disclosures, ongoing insider selling, and the company's expansion into new-vehicle sales, while sentiment remains deeply polarized between those betting on continued short squeezes and those anticipating a major fundamental correction.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck & Co. is currently trending as the market closely monitors potential M&A activity, with community members actively discussing its strategic pipeline acquisitions and its aggressive pursuit of oncology assets to counter upcoming patent cliffs for Keytruda. Investors are specifically focused on the company's interest in emerging biotech partnerships and clinical trial outcomes, viewing it as a primary contender in major upcoming pharmaceutical bidding wars.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors monitor regulatory progress for AXPAXLI, with significant community discourse centered on its potential superiority over current standards for wet AMD and ongoing speculation regarding acquisition interest from major industry players. While bullish sentiment focuses on clinical data and institutional backing, some market participants remain cautious, highlighting debates over the path to FDA approval and the competitive landscape.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is trending as investors monitor a shift toward broader market rotation and potential M&A activity, with the community actively debating the durability of recent clinical data readouts across the sector. Speculation regarding the impact of upcoming data and possible regulatory changes is fueling intense discussion, while traders carefully watch price support levels amidst broader equity market fluctuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InMode Appoints Moshik Itzkovich As CFO, Shlomo Nass As Chairman

(RTTNews) - InMode Ltd. (INMD), a medtech company, Wednesday announced the appointment of Moshik Itzkovich as Chief Financial Officer and Shlomo Nass as Chairman of the company, effective immediately...

InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer

InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer PR Newswire YOKNEAM, Israel, May 20, 2026 YOKNEAM, Israel, May 20, 2026 /PRNewswire...

InMode (NASDAQ:INMD) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS

InMode (NASDAQ:INMD - Get Free Report) posted its quarterly earnings data on Wednesday. The healthcare company reported $0.25 EPS for the quarter, missing analysts' consensus estimates of $0.30 by ($0.05). InMode had a return on equity of 14.52% and a net margin of 25.33%.The company had revenue of...

InMode Q1 Earnings Call Highlights

InMode (NASDAQ:INMD) reported first-quarter 2026 results that management said came in "in line with our expectation," alongside early signs of stabilization in demandparticularly in the U.S.following a restructuring of its North America commercial organization.

Management points to early stabiliz...

InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase

InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase PR Newswire YOKNEAM, Israel, May 6...

InMode (INMD) to Release Earnings on Wednesday

InMode (NASDAQ:INMD) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-inmode-ltd-stock...

InMode (NASDAQ:INMD) Stock Price Passes Above 200 Day Moving Average - What's Next?

InMode (NASDAQ:INMD) Stock Passes Above 200-Day Moving Average - Here's Why...

InMode Flags Slow Aesthetic Demand, Picofy-Driven Q1 Lift and Margin Pressure at Needham Conference

InMode (NASDAQ:INMD) discussed recent operating trends, product launches, margin pressure, and capital allocation during a fireside chat at the 25th Annual Needham Healthcare Conference. Needham & Company's Mike Matson hosted the session with CEO Moshe Mizrahy and CFO Yair Malca.

Q1 performance...

InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M InMode...

InMode Ltd. (NASDAQ:INMD) Receives Consensus Rating of "Hold" from Analysts

Shares of InMode Ltd. (NASDAQ:INMD - Get Free Report) have been assigned an average recommendation of "Hold" from the nine research firms that are currently covering the stock, Marketbeat.com...

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Inmode Ltd

InMode Shares Are Rallying After Hours – What’s The Takeover Offer?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

INMDInmode Ltd

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INMD News